REQUEST A DEMO
Total
USD $0.00
Search more companies

ZENTIVA PHARMA Kft. (Hungary)

Main Activities: Other Miscellaneous Nondurable Goods Merchant Wholesalers
Full name: ZENTIVA PHARMA Gyogyszermarketing Kereskedelmi es Szolgaltato Korlatolt Felelossegu Tarsasag Profile Updated: August 06, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English & Hungarian Download a sample report

ZENTIVA PHARMA Gyogyszermarketing Kereskedelmi es Szolgaltato Korlatolt Felelossegu Tarsasag is a pharmaceutical company that operates multiple manufacturing sites worldwide and produces medicines, including brands and generic products, with the aim of making healthcare accessible to all. The company claims to have a strong presence in various regions.

Headquarters
Konyves Kalman korut 11/C
Budapest; Budapest; Postal Code: 1097

Contact Details: Purchase the ZENTIVA PHARMA Kft. report to view the information.

Website: http://www.aramispharma.hu

Basic Information
Total Employees:
Purchase the ZENTIVA PHARMA Kft. report to view the information.
Registered Capital:
Purchase the ZENTIVA PHARMA Kft. report to view the information.
Financial Auditors:
Purchase the ZENTIVA PHARMA Kft. report to view the information.
Incorporation Date:
July 21, 2006
Key Executives
Purchase this report to view the information.
Managing Director
Ownership Details
Purchase this report to view the information.
52.37%
Purchase this report to view the information.
Subsidiaries
Alvopharm Kft. v.a.
Company Performance
Financial values in the chart are available after ZENTIVA PHARMA Kft. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency HUF. Absolute financial data is included in the purchased report.
Net sales revenue
-0.69%
Total operating revenue
0.37%
Operating profit (EBIT)
N/A
EBITDA
N/A
Net Profit (Loss) for the Period
291.66%
Total Assets
4.46%
Total Equity
10.98%
Operating Profit Margin (ROS)
N/A
Net Profit Margin
17.65%
Return on Equity (ROE)
7.09%
Debt/Equity
-0.27%
Quick Ratio
1.6%
Cash Ratio
1.47%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?